Back to Newsroom

Eutilex Completes $18 Million Series A Financing to Advance Immuno-Oncology Programs

SEOUL, South Korea, Dec. 8, 2016 /PRNewswire/ — Eutilex Co. Ltd. today announced that it has completed a $21 billion KRW (US $18.9M) Series A financing. This financing round included participation from DS Asset Management, Kolon Investment, G.N. Tech Venture and SNU Bio Angel. This new funding brings the total capital raised by Eutilex to 30.5 billion KRW (US $27.7M) since its founding in 2015.

Click here to read the full release